Engine No 1 LLC’s West Pharmaceutical WST Stock Holding History

Engine No 1 LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-507	Closed	-$238K	–	293
2021 Q4	$238K	Buy	+507	New	+$218K	0.05%	263

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Engine No 1 LLC's WST Position: Q1 2022 in Review

Engine No 1 LLC sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 507 shares — an estimated $238K sold.

Engine No 1 LLC first reported a position in WST in Q4 2021 and held it in 1 quarter. The position peaked at $238K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

Engine No 1 LLC reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Engine No 1 LLC sold 507 West Pharmaceutical shares in Q1 2022, an estimated $238K.
Engine No 1 LLC first reported a position in West Pharmaceutical in Q4 2021 and held it in 1 quarter.
Engine No 1 LLC's West Pharmaceutical position peaked at $238K in Q4 2021.
717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Engine No 1 LLC's 13F filing for Q1 2022, filed 13 May 2022.